Insight Molecular Diagnostics, Inc. (IMDX)
7.50
+0.50
(+7.14%)
USD |
NASDAQ |
Dec 31, 16:00
7.50
0.00 (0.00%)
After-Hours: 20:00
Insight Molecular Diagnostics Cash from Investing (Quarterly): -1.05M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| FONAR Corp. | -2.367M |
| XWELL, Inc. | 1.715M |
| ProPhase Labs, Inc. | 0.00 |
| Veracyte, Inc. | 48.26M |
| Exagen, Inc. | -0.275M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -4.502M |
| Cash from Financing (Quarterly) | -0.12M |
| Free Cash Flow | -23.91M |
| Free Cash Flow Per Share (Quarterly) | -0.1733 |
| Free Cash Flow to Equity (Quarterly) | -5.305M |
| Free Cash Flow to Firm (Quarterly) | -5.523M |
| Free Cash Flow Yield | -11.90% |